Sensitivity and specificity of body mass index in determining obesity in children

Mehnoosh Samadi1, Haleh Sadrzade-Yeganeh1, Leila Azadbakht2

  • 1Department of Community Nutrition, School of Nutritional Sciences and Dietetics and School of Public Health, Tehran University of Medical Sciences, Isfahan, Iran.

Insights

Fat Mass Index (FMI) is more accurate for identifying childhood obesity than Body Mass Index (BMI). This study found FMI better detects true obesity in girls aged 8-10 years.

Area of Science:

  • Pediatric Endocrinology
  • Nutritional Science
  • Public Health

Background:

  • Childhood obesity is a growing public health concern.
  • Accurate assessment of obesity in children is crucial for timely intervention.
  • Existing methods like Body Mass Index (BMI) may have limitations in accurately identifying excess fat mass.

Purpose of the Study:

  • To compare the sensitivity and specificity of Body Mass Index (BMI) against the Center for Disease Control 2000 (CDC) percentiles.
  • To evaluate Fat Mass Index (FMI) as a more precise indicator of true obesity in children.
  • To assess the diagnostic performance of BMI in identifying obesity based on FMI criteria.

Main Methods:

  • A cross-sectional study involving 410 primary school girls aged 8-10 years.
  • Body Mass Index (BMI) calculated from height and weight.
  • Fat Mass Index (FMI) measured using a body composition analyzer (BCA).
  • Receiver Operating Characteristic (ROC) curve analysis to determine BMI's performance against FMI.

Main Results:

  • The area under the ROC curve for obesity detection was 0.75.
  • A BMI cutoff of 21.2 kg/m² demonstrated 79% sensitivity and 73% specificity for identifying obesity based on FMI.
  • Agreement between BMI and FMI for obesity classification was moderate (Kappa coefficient = 0.5).

Conclusions:

  • Fat Mass Index (FMI) appears to be a more accurate measure for determining obesity in children compared to Body Mass Index (BMI).
  • While BMI identified 79% of FMI-defined obese children, it also misclassified 27% of non-obese children as obese.
  • Further research is warranted to validate FMI's utility in pediatric obesity assessment.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
368
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
1.9K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324